KPC Pharmaceuticals,Inc. (SHA:600422)
China
· Delayed Price · Currency is CNY 12.15
-0.01 (-0.08%)
Mar 10, 2026, 3:00 PM CST
KPC Pharmaceuticals,Inc. Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 9,197 | 9,508 | 11,998 | 15,812 | 10,707 | 8,379 | Upgrade
|
| Market Cap Growth | -25.14% | -20.76% | -24.12% | 47.68% | 27.78% | 27.75% | Upgrade
|
| Enterprise Value | 9,678 | 9,988 | 10,979 | 15,195 | 10,654 | 7,992 | Upgrade
|
| Last Close Price | 12.15 | 12.56 | 15.53 | 20.16 | 13.53 | 10.34 | Upgrade
|
| PE Ratio | 26.41 | 27.17 | 18.51 | 29.24 | 27.94 | 16.50 | Upgrade
|
| Forward PE | 13.93 | 13.01 | 18.24 | 23.08 | 17.54 | 13.16 | Upgrade
|
| PS Ratio | 1.40 | 1.45 | 1.43 | 1.88 | 1.29 | 1.01 | Upgrade
|
| PB Ratio | 1.34 | 1.39 | 1.78 | 1.99 | 2.08 | 1.70 | Upgrade
|
| P/TBV Ratio | 2.68 | 2.77 | 3.59 | 3.42 | 2.36 | 1.96 | Upgrade
|
| P/FCF Ratio | - | - | 16.47 | 24.53 | 70.37 | 542.13 | Upgrade
|
| P/OCF Ratio | - | - | 14.85 | 20.96 | 42.17 | 33.30 | Upgrade
|
| PEG Ratio | - | 1.18 | 1.18 | 1.18 | 1.18 | 1.18 | Upgrade
|
| EV/Sales Ratio | 1.47 | 1.52 | 1.31 | 1.80 | 1.29 | 0.97 | Upgrade
|
| EV/EBITDA Ratio | 15.78 | 16.29 | 11.38 | 17.77 | 14.32 | 14.07 | Upgrade
|
| EV/EBIT Ratio | 21.58 | 22.27 | 13.72 | 22.35 | 18.91 | 19.53 | Upgrade
|
| EV/FCF Ratio | - | - | 15.07 | 23.57 | 70.02 | 517.08 | Upgrade
|
| Debt / Equity Ratio | 0.25 | 0.25 | 0.12 | 0.11 | 0.22 | 0.17 | Upgrade
|
| Debt / EBITDA Ratio | 2.76 | 2.76 | 0.84 | 1.01 | 1.48 | 1.40 | Upgrade
|
| Debt / FCF Ratio | - | - | 1.14 | 1.40 | 7.49 | 53.57 | Upgrade
|
| Net Debt / Equity Ratio | -0.16 | -0.16 | -0.28 | -0.15 | -0.16 | -0.18 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.74 | -1.74 | -1.98 | -1.41 | -1.13 | -1.60 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -2.62 | -1.86 | -5.51 | -58.67 | Upgrade
|
| Asset Turnover | - | - | 0.68 | 0.78 | 0.90 | 0.97 | Upgrade
|
| Inventory Turnover | - | - | 2.88 | 2.63 | 2.72 | 2.70 | Upgrade
|
| Quick Ratio | - | - | 1.22 | 1.59 | 1.21 | 1.12 | Upgrade
|
| Current Ratio | - | - | 1.56 | 2.11 | 1.74 | 1.77 | Upgrade
|
| Return on Equity (ROE) | 5.15% | 5.15% | 10.22% | 9.81% | 7.65% | 10.76% | Upgrade
|
| Return on Assets (ROA) | - | - | 4.02% | 3.91% | 3.84% | 2.99% | Upgrade
|
| Return on Invested Capital (ROIC) | 5.73% | 6.24% | 11.10% | 10.05% | 10.92% | 8.71% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 11.20% | 8.10% | 10.20% | 7.60% | Upgrade
|
| Earnings Yield | 3.80% | 3.68% | 5.40% | 3.42% | 3.58% | 6.06% | Upgrade
|
| FCF Yield | - | - | 6.07% | 4.08% | 1.42% | 0.18% | Upgrade
|
| Dividend Yield | 2.47% | - | 1.93% | 0.99% | 1.18% | 2.61% | Upgrade
|
| Payout Ratio | - | - | 26.62% | 27.11% | 60.37% | 40.10% | Upgrade
|
| Buyback Yield / Dilution | -0.95% | -0.95% | 1.05% | -1.36% | 0.84% | 0.19% | Upgrade
|
| Total Shareholder Return | 1.54% | -0.95% | 2.98% | -0.37% | 2.02% | 2.80% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.